Hu et al., 2017 - Google Patents
Purification, characterization, in vitro anti-hepatic fibrosis activity of bioactive peptides derived from Carapax Trionycis hydrolysatesHu et al., 2017
- Document ID
- 6393461698864944121
- Author
- Hu C
- Peng X
- Tang Y
- Liu Y
- Hu Z
- Gao J
- Publication year
- Publication venue
- Journal of Chinese Pharmaceutical Sciences
External Links
Snippet
Anti-hepatic fibrosis peptide from Carapax Trionycis was purified, characterized, and inhibitory effect was assessed. Carapax Trionycis extract peptide hydrolysates (CTEPHs) were separated by ultrafiltration, Sephadex G-15 gel chromatography and RP-HPLC. One …
- 108090000765 processed proteins & peptides 0 title abstract description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Identification of antioxidative peptides from defatted walnut meal hydrolysate with potential for improving learning and memory | |
| Toopcham et al. | Bioavailability of angiotensin I-converting enzyme (ACE) inhibitory peptides derived from Virgibacillus halodenitrificans SK1-3-7 proteinases hydrolyzed tilapia muscle proteins | |
| Tavares et al. | Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: In vitro effect and stability to gastrointestinal enzymes | |
| Liu et al. | Purification and identification of an ACE inhibitory peptide from walnut protein | |
| Udenigwe et al. | Low molecular weight flaxseed protein-derived arginine-containing peptides reduced blood pressure of spontaneously hypertensive rats faster than amino acid form of arginine and native flaxseed protein | |
| CN104968360B (en) | For treatment and/or nursing skin, the compound and their make-up and beauty or pharmaceutical composition of hair and/or mucous membrane | |
| Hayes et al. | Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats | |
| WO2019191633A3 (en) | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof | |
| PE20190352A1 (en) | GDF 15 FUSION PROTEINS AND USES OF THEM | |
| Lin et al. | Transport of soybean protein-derived antihypertensive peptide LSW across Caco-2 monolayers | |
| EA202190906A1 (en) | RECOMBINANT PREPARATION OF COLLAGEN PEPTIDES AND THEIR APPLICATION | |
| BR112017001940A2 (en) | interleukin-2 / alpha receptor interleukin-2 fusion proteins and processes of use | |
| BR0011152A (en) | Neuronic exocytosis inhibitor peptides, cosmetic and pharmaceutical compositions containing them | |
| EP3939606A3 (en) | Improved methods and compounds for eliminating immune responses to therapeutic agents | |
| Gildberg et al. | Angiotensin I-converting enzyme inhibitory activity in a hydrolysate of proteins from Northern shrimp (Pandalus borealis) and identification of two novel inhibitory tri-peptides | |
| IN2012DN02981A (en) | ||
| AR065074A1 (en) | SIGNALING PEPTIDES | |
| PH12016500705A1 (en) | Calcitonin mimetics for treating diseases and disorders | |
| EP4349360A3 (en) | Peptide exhibiting wrinkle-improving activity and uses thereof | |
| Nongonierma et al. | Insulinotropic properties of whey protein hydrolysates and impact of peptide fractionation on insulinotropic response | |
| CL2012001380A1 (en) | Pharmaceutical or cosmetic composition comprising the coriolysin l polypeptide, the highly acidic proteins vapi, vapii, vapiii, and one or more nucleic acid molecules encoding any of the aforementioned polypeptides; nucleic acid; vector, host cell; method of preparing said polypeptides; and cosmetic method for exfoliating and / or moisturizing the skin of an animal. | |
| PE20161406A1 (en) | TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS AND USE OF THEM | |
| Hu et al. | Purification, characterization, in vitro anti-hepatic fibrosis activity of bioactive peptides derived from Carapax Trionycis hydrolysates | |
| BR112018076674A2 (en) | fusion protein between short-form rod derived cone viability factor and a hydrophilic peptide | |
| Tan et al. | Cytotoxic and anticancer properties of the Malaysian mangrove pit viper (Trimeresurus purpureomaculatus) venom and its disintegrin (purpureomaculin) |